课题基金 / 基金详情

Autophagy as a microenvironmental regulator of tumorigenesis and resistance

Autophagy as a microenvironmental regulator of tumorigenesis and resistance
自噬作为肿瘤发生和耐药性的微环境调节剂
批准号:
9333289
负责人:
GABRIELE BERGERS
金额:
$42.22万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-08-31

项目摘要

项目成果

GABRIELE BERGERS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autophagy is an evolutionarily conserved lysosomal degradation process crucial for adaptation to stress and for cellular homeostasis. To date, the rationale for targeting autophagy against cancer has been attributed to its cell-autonomous effects as a tumor cell survival pathway. In contrast, the role of autophagy in the development and function of the tumor microenvironment, a critical mediator of tumor initiation, progression and response to therapy, remains obscure. This project merges our expertise in autophagy and angiogenesis to define the functions of the autophagy pathway in the microenvironmental control of invasion and angiogenesis. We seek to answer two fundamental questions in the field. First, how does tumor cell autophagy generate a microenvironment conducive for survival and invasion? Second, is endothelial cell autophagy a prerequisite for the initiation of angiogenesis and during reneovascularization to escape therapeutic vascular growth restrictions imposed by anti-angiogenic therapy? Our preliminary studies implicate autophagy in the production of pro-migratory cytokines, thereby facilitating tumor cell invasion directly, or by activating monocytes via paracrine signaling cues. In addition, our pilot studies indicate that endothelial cell-targete autophagy deletion impairs neovascularization in vivo, thereby revealing a cell specific functional requirement for autophagy for angiogenesis. Based on these results, we will leverage powerful in vivo cancer models uniquely available in our laboratories to pursue two specific aims. In Aim 1, we will define the role of tumor cell autophagy in promoting glioblastoma multiforme (GBM) invasion and resistance to anti-angiogenic therapy. In Aim 2, we will determine the functions of endothelial cell autophagy during neovascularization and response to anti-angiogenic therapy. Overall, this proposal will define new interconnections between autophagy and the microenvironment that direct cancer cell invasion, angiogenesis and therapeutic resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inter-regulatory function of immune-modulation and angiogenesis in cancer
Inter-regulatory function of immune-modulation and angiogenesis in cancer
Autophagy as a microenvironmental regulator of tumorigenesis and resistance
Autophagy as a microenvironmental regulator of tumorigenesis and resistance
海外基金